Table 6.

Quantitative results of Cell cycle distribution of MCF-7, A549 and Caco-2 cells treated with the indicated IC₅₀ concentrations of cisplatin and Pt(TSC)Cl complex for 48 h determined by staining the DNA content of the cell followed by flow cytometry. The percentage of cells in G0/G1, S or G2/M phase is indicated.

	A549			MCF-7			Caco-2
	Control	Cis	Pt(TSC)Cl complex	Control	Cis	Pt(TSC)Cl complex	Control	Cis	Pt(TSC)Cl complex
SubG1	0.32	0.42	21.78	0.14	6.8	4.95	4.55	10.28	50.82
G0/G1	66.38	66.94	47.71	67.38	37.21	53.17	54.68	41.73	30.34
S	14.56	16.13	13.94	16.85	37.43	27.72	19.90	19.61	14.91
G2/M	17.72	16.08	15.66	15.73	15.88	14.70	21.45	27.13	5.08

*Cis: Cisplatin, A549: Human lung cancer cells, Caco-2: Human colon cancer cells, MCF-7 Human breast cancer cells.